Short Interest in Ambu A/S (OTCMKTS:AMBBY) Grows By 350.0%

Ambu A/S (OTCMKTS:AMBBY) was the recipient of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 900 shares, a growth of 350.0% from the September 30th total of 200 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is currently 2.3 days.

Ambu A/S Stock Performance

Shares of OTCMKTS:AMBBY opened at $18.28 on Friday. The firm’s 50 day simple moving average is $19.61 and its 200 day simple moving average is $18.92. Ambu A/S has a fifty-two week low of $9.45 and a fifty-two week high of $22.65. The company has a market capitalization of $4.30 billion and a price-to-earnings ratio of 91.40. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.52 and a quick ratio of 1.51.

Ambu A/S (OTCMKTS:AMBBY) last announced its quarterly earnings results on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a net margin of 8.55% and a return on equity of 8.09%. The company had revenue of $199.56 million for the quarter.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.